Sunday, May 03rd
Last update09:08:51 AM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 The Centers for Medicare and Medicaid Services (CMS) unintentionally published Social Security data for at least... |
 A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges... | ||
 A federal appeals court late Friday blocked the ability of doctors to prescribe the abortion pill... |
 A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while... |
